HKMA announces 5% annual rate for Silver Bond 2026 fifth payment, with fixed rate outpacing 1.17% inflation-linked floating rate by wide margin. (Read More)HKMA announces 5% annual rate for Silver Bond 2026 fifth payment, with fixed rate outpacing 1.17% inflation-linked floating rate by wide margin. (Read More)

Hong Kong Silver Bond Pays 5% as Fixed Rate Beats Inflation Floor

2 min read

Hong Kong Silver Bond Pays 5% as Fixed Rate Beats Inflation Floor

James Ding Feb 03, 2026 09:14

HKMA announces 5% annual rate for Silver Bond 2026 fifth payment, with fixed rate outpacing 1.17% inflation-linked floating rate by wide margin.

Hong Kong Silver Bond Pays 5% as Fixed Rate Beats Inflation Floor

Hong Kong's Silver Bond holders will receive a 5% annual interest rate for the fifth payment cycle, the Hong Kong Monetary Authority confirmed on February 3, as the fixed rate floor substantially exceeded the inflation-linked alternative.

The announcement covers Issue Number 03GB2608R, with payment scheduled for February 20, 2026. Bondholders benefit from the instrument's dual-rate structure, which guarantees the higher of either a 5% fixed rate or a floating rate tied to local inflation.

This time around, it wasn't close. The floating rate came in at just 1.17%, calculated from Hong Kong's Composite Consumer Price Index changes over the preceding six months. That spread of nearly 4 percentage points between the guaranteed floor and inflation tells a clear story about the city's price environment.

Inflation Running Cool

The CPI data underlying the floating rate calculation shows Hong Kong's inflation remained subdued throughout the second half of 2025. Monthly readings ranged from 1.0% in July to 1.4% in December, averaging out to the 1.17% figure.

For retail investors who purchased these bonds when they launched in July 2023, the consistent 5% payouts represent solid returns in a low-inflation environment. The fixed rate has effectively acted as the operative rate throughout most of the bond's life, given Hong Kong's muted price pressures.

What This Means for Holders

Silver Bonds target Hong Kong residents aged 60 and above, offering government-backed income with inflation protection as a backstop. The structure works both ways—when inflation runs hot, holders get compensated; when it doesn't, they still collect a respectable fixed return.

With this fifth payment, the 2026 series enters its final year before maturity. Holders have one more interest payment ahead before principal redemption. Given current inflation trends, the 5% fixed rate appears likely to remain the binding constraint unless Hong Kong experiences an unexpected price surge in the coming months.

The HKMA continues administering these instruments under the Government Bond Programme's Retail Bond Issuance framework, maintaining the city's commitment to providing accessible fixed-income options for senior residents.

Image source: Shutterstock
  • hong kong bonds
  • hkma
  • fixed income
  • inflation
  • retail bonds
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29